Compare LWLG & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LWLG | BVS |
|---|---|---|
| Founded | 1991 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Containers/Packaging | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 578.6M | 482.9M |
| IPO Year | 2011 | 2016 |
| Metric | LWLG | BVS |
|---|---|---|
| Price | $4.97 | $8.71 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $13.33 |
| AVG Volume (30 Days) | ★ 1.4M | 253.2K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 79.12 |
| EPS | N/A | ★ 0.12 |
| Revenue | $95,605.00 | ★ $573,280,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $6.78 |
| P/E Ratio | ★ N/A | $73.25 |
| Revenue Growth | ★ 136.05 | 11.89 |
| 52 Week Low | $0.79 | $5.81 |
| 52 Week High | $6.26 | $11.25 |
| Indicator | LWLG | BVS |
|---|---|---|
| Relative Strength Index (RSI) | 71.61 | 63.49 |
| Support Level | $3.84 | $6.37 |
| Resistance Level | $6.12 | $9.03 |
| Average True Range (ATR) | 0.32 | 0.34 |
| MACD | 0.17 | 0.02 |
| Stochastic Oscillator | 95.57 | 77.46 |
Lightwave Logic Inc is a United States-based development stage company moving toward commercialization of next-generation electro-optic photonic devices made on its P2IC technology platform which uses in-house proprietary high-activity and high-stability organic polymers. Electro-optical devices convert data from electric signals into optical signals for multiple applications. It designs and synthesizes organic chromophores for use in its own proprietary electro-optic polymer systems and photonic device designs.
Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Geographical presence is in the United States which derives key revenue, and International markets.